Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Titre (en) » - entrée « interleukin »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
interim < interleukin < interleukins  Facettes :

List of bibliographic references indexed by interleukin

Number of relevant bibliographic references: 460.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000031 (2020) Jerome Razanamahery [France] ; Sebastien Humbert [France] ; Helder Gil [France] ; Kevin Bouiller [France] ; Nadine Magy-Bertrand [France]Tropheryma Whipplei infection mimicking giant cell arteritis flare in a patient treated with interleukin-6 receptor blocker tocilizumab.
000052 (2020) Yasuhiko Hirabayashi [Japon]Tocilizumab, an anti-interleukin-6 receptor antibody, efficiently ameliorates persistent joint inflammation in rheumatoid arthritis.
000095 (2020) Chi Zhang [République populaire de Chine] ; Zhao Wu [République populaire de Chine] ; Jia-Wen Li [République populaire de Chine] ; Hong Zhao [République populaire de Chine] ; Gui-Qiang Wang [République populaire de Chine]The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality
000136 (2020) Gehan Elolemy [Koweït] ; Abdulrahman Al Rashidi [Koweït] ; Ahmed Dehrab [Koweït] ; Ammar Almathkouri [Koweït] ; Alex Varghese [Koweït] ; Mustafa Chikhly [Koweït] ; Fatema Alkhawaja [Koweït]Successful treatment of refractory lupus erythematosus profundus with the interleukin-6 antagonist tocilizumab: a case report.
000180 (2020) Emily Yi-Chih Ting ; Albert C. Yang [États-Unis] ; Shih-Jen Tsai [Taïwan]Role of Interleukin-6 in Depressive Disorder
000256 (2020) Francesco Bennardo [Italie] ; Caterina Buffone [Italie] ; Amerigo Giudice [Italie]New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws.
000281 (2020) Haihua Zhang [République populaire de Chine] ; Tao Wang [République populaire de Chine] ; Zhifa Han [République populaire de Chine] ; Guiyou Liu [République populaire de Chine]Mendelian randomization study to evaluate the effects of interleukin-6 signaling on four neurodegenerative diseases.
000310 (2020) Guoqiang Zhang [République populaire de Chine] ; Hayato Iwase [États-Unis] ; Liaoran Wang [États-Unis] ; Takayuki Yamamoto [États-Unis] ; Abhijit Jagdale [États-Unis] ; David Ayares [États-Unis] ; Yong Li [République populaire de Chine] ; David K C. Cooper [États-Unis] ; Hidetaka Hara [États-Unis]Is interleukin-6 receptor blockade (tocilizumab) beneficial or detrimental to pig-to-baboon organ xenotransplantation?
000318 (2020) Peter Uciechowski [Allemagne] ; Wolfram C M. Dempke [Allemagne]Interleukin-6: A Masterplayer in the Cytokine Network.
000319 (2020) Paula Sanchis ; Olaya Fernández-Gayol [États-Unis] ; Gemma Comes ; Anna Escrig ; Mercedes Giralt ; Richard D. Palmiter ; Juan HidalgoInterleukin-6 Derived from the Central Nervous System May Influence the Pathogenesis of Experimental Autoimmune Encephalomyelitis in a Cell-Dependent Manner
000320 (2020) Rachel A. O Eefe ; Neil E. Bhola ; David S. Lee ; Daniel E. Johnson ; Jennifer R. GrandisInterleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance
000331 (2020) Anne Y. Liu [États-Unis]Infectious Implications of Interleukin-1, Interleukin-6, and T Helper Type 2 Inhibition.
000341 (2020) Claas Hinze [Allemagne] ; Sabrina Fuehner [Allemagne] ; Christoph Kessel [Allemagne] ; Helmut Wittkowski [Allemagne] ; Elke Lainka [Allemagne] ; Melanie Baehr [Allemagne] ; Boris Hügle [Allemagne] ; Johannes-Peter Haas [Allemagne] ; Gerd Ganser [Allemagne] ; Elisabeth Wei Barth-Riedel [Allemagne] ; Annette Jansson [Allemagne] ; Dirk Foell [Allemagne]Impact of IL1RN Variants on Response to Interleukin-1 Blocking Therapy in Systemic Juvenile Idiopathic Arthritis.
000389 (2020) Koichi Nakamura ; Tomoki Nakamura ; Takahiro Iino ; Tomohito Hagi ; Kouji Kita ; Kunihiro Asanuma ; Akihiro SudoExpression of Interleukin-6 and the Interleukin-6 Receptor Predicts the Clinical Outcomes of Patients with Soft Tissue Sarcomas
000400 (2020) Muhammad Aziz [États-Unis] ; Rawish Fatima [États-Unis] ; Ragheb Assaly [États-Unis]Elevated Interleukin-6 and Severe COVID-19: A Meta-Analysis.
000463 (2020) John D. Koerner [États-Unis] ; Dessislava Z. Markova [États-Unis] ; Greg D. Schroeder [États-Unis] ; Christopher L. Antonacci [États-Unis] ; Joseph Mendelis [États-Unis] ; Alexander R. Vaccaro [États-Unis] ; D. Greg Anderson [États-Unis] ; Chris K. Kepler [États-Unis]Correlation of Early Outcomes and Intradiscal Interleukin-6 Expression in Lumbar Fusion Patients
000497 (2020) Satoshi Tsukuda [Japon] ; Tsukasa Ikeura [Japon] ; Takashi Ito [Japon] ; Koh Nakamaru [Japon] ; Masataka Masuda [Japon] ; Yuichi Hori [Japon] ; Manami Ikemune [Japon] ; Masato Yanagawa [Japon] ; Toshihiro Tanaka [Japon] ; Takashi Tomiyama [Japon] ; Takashi Yamaguchi [Japon] ; Yugo Ando [Japon] ; Kazushige Uchida [Japon] ; Toshiro Fukui [Japon] ; Akiyoshi Nishio [Japon] ; Rika Terasawa [Japon] ; Noboru Tanigawa [Japon] ; Kazuichi Okazaki [Japon]Clinical implications of elevated serum interleukin-6 in IgG4-related disease
000525 (2020) Bingwen Liu [République populaire de Chine] ; Min Li [République populaire de Chine] ; Zhiguang Zhou [République populaire de Chine] ; Xuan Guan [États-Unis] ; Yufei Xiang [République populaire de Chine]Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?
000579 (2020) Levent Kiliç [Turquie] ; Ömer Karada [Turquie] ; Abdulsamet Erden [Turquie] ; Alper Sari [Turquie] ; Berkan Arma An [Turquie] ; Gözde Kübra Yardimci [Turquie] ; Esra Firat [Turquie] ; Umut Kalyoncu [Turquie] ; Ule Apra B Lgen [Turquie] ; Sedat K Raz [Turquie] ; Hsan Ertenl [Turquie] ; Ali Akdo An [Turquie]Anti-interleukin-6 (tocilizumab) therapy in Takayasu’s arteritis: a real life experience
000614 (2020) Haneul Kim [Corée du Sud] ; Seungye Baek [Corée du Sud] ; Seung-Min Hong [Corée du Sud] ; Jaeseon Lee [Corée du Sud] ; Seung Min Jung [Corée du Sud] ; Jennifer Lee [Corée du Sud] ; Mi-La Cho [Corée du Sud] ; Seung-Ki Kwok [Corée du Sud] ; Sung-Hwan Park [Corée du Sud]1,25-dihydroxy Vitamin D3 and Interleukin-6 Blockade Synergistically Regulate Rheumatoid Arthritis by Suppressing Interleukin-17 Production and Osteoclastogenesis
000655 (2019) Takuya Inoue [Japon] ; Masataka Kohno [Japon] ; Hidetake Nagahara [Japon] ; Ken Murakami [Japon] ; Tomoya Sagawa [Japon] ; Akiko Kasahara [Japon] ; Shunya Kaneshita [Japon] ; Takashi Kida [Japon] ; Kazuki Fujioka [Japon] ; Makoto Wada [Japon] ; Hiroshi Nakada [Japon] ; Timothy Hla [États-Unis] ; Yutaka Kawahito [Japon]Upregulation of sphingosine-1-phosphate receptor 3 on fibroblast-like synoviocytes is associated with the development of collagen-induced arthritis via increased interleukin-6 production

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "interleukin" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "interleukin" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    interleukin
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021